The Discounted Cash Flow (DCF) valuation of Amphastar Pharmaceuticals Inc (AMPH) is 37.70 USD. With the latest stock price at 27.00 USD, the upside of Amphastar Pharmaceuticals Inc based on DCF is 39.6%.
Based on the latest price of 27.00 USD and our DCF valuation, Amphastar Pharmaceuticals Inc (AMPH) is a buy. buying AMPH stocks now will result in a potential gain of 39.6%.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 9.9% | 8.3% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 28.40 - 53.91 | 37.70 |
| Upside | 5.2% - 99.7% | 39.6% |